Waters Corporation (WAT) to Post Q1 2018 Earnings of $1.76 Per Share, Jefferies Group Forecasts
Waters Corporation (NYSE:WAT) – Jefferies Group reduced their Q1 2018 earnings estimates for Waters Corporation in a note issued to investors on Thursday. Jefferies Group analyst B. Couillard now anticipates that the medical instruments supplier will post earnings of $1.76 per share for the quarter, down from their prior forecast of $1.77. Jefferies Group has a “Hold” rating and a $175.00 price target on the stock. Jefferies Group also issued estimates for Waters Corporation’s Q2 2018 earnings at $1.97 EPS and Q3 2018 earnings at $1.97 EPS.
WAT has been the topic of several other reports. Cowen and Company reiterated a “hold” rating and issued a $190.00 target price on shares of Waters Corporation in a report on Friday, November 3rd. BidaskClub lowered shares of Waters Corporation from a “strong-buy” rating to a “buy” rating in a report on Friday, July 28th. Zacks Investment Research lowered shares of Waters Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 27th. Deutsche Bank AG increased their target price on shares of Waters Corporation from $199.00 to $200.00 and gave the stock a “hold” rating in a report on Wednesday, October 25th. Finally, Bank of America Corporation reiterated a “neutral” rating and issued a $192.00 target price (up from $180.00) on shares of Waters Corporation in a report on Friday, July 21st. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $193.62.
Waters Corporation (NYSE WAT) opened at $194.64 on Monday. The company has a quick ratio of 5.71, a current ratio of 6.16 and a debt-to-equity ratio of 0.66. The firm has a market cap of $15,366.58, a P/E ratio of 26.83, a P/E/G ratio of 2.80 and a beta of 0.83. Waters Corporation has a twelve month low of $133.35 and a twelve month high of $199.78.
Waters Corporation (NYSE:WAT) last announced its quarterly earnings data on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.03. Waters Corporation had a net margin of 24.34% and a return on equity of 23.61%. The business had revenue of $565.58 million for the quarter, compared to analyst estimates of $555.25 million. During the same period in the prior year, the business posted $1.57 earnings per share. Waters Corporation’s revenue was up 7.4% compared to the same quarter last year.
Institutional investors have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP grew its position in Waters Corporation by 0.7% in the second quarter. Dimensional Fund Advisors LP now owns 209,081 shares of the medical instruments supplier’s stock valued at $38,436,000 after purchasing an additional 1,448 shares in the last quarter. Assenagon Asset Management S.A. bought a new position in Waters Corporation in the third quarter valued at $3,446,000. Advisory Services Network LLC grew its position in shares of Waters Corporation by 6.0% in the 2nd quarter. Advisory Services Network LLC now owns 1,145 shares of the medical instruments supplier’s stock valued at $210,000 after acquiring an additional 65 shares during the period. UBS Asset Management Americas Inc. grew its position in shares of Waters Corporation by 46.7% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 374,472 shares of the medical instruments supplier’s stock valued at $68,843,000 after acquiring an additional 119,130 shares during the period. Finally, Chicago Equity Partners LLC bought a new position in shares of Waters Corporation in the 2nd quarter valued at about $3,230,000. 91.82% of the stock is owned by institutional investors and hedge funds.
In related news, SVP Rohit Khanna sold 26,913 shares of the firm’s stock in a transaction on Friday, October 27th. The shares were sold at an average price of $197.93, for a total value of $5,326,890.09. Following the completion of the transaction, the senior vice president now owns 13,677 shares of the company’s stock, valued at $2,707,088.61. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Elizabeth B. Rae sold 12,000 shares of the firm’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $197.95, for a total transaction of $2,375,400.00. Following the completion of the transaction, the senior vice president now directly owns 18,129 shares of the company’s stock, valued at approximately $3,588,635.55. The disclosure for this sale can be found here. In the last ninety days, insiders sold 57,313 shares of company stock valued at $11,120,642. 5.07% of the stock is owned by insiders.
Waters Corporation Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Stock Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related stocks with our FREE daily email newsletter.